Sale

Bnp & Ntprobnp Market by Type (Bnp Test Kits, Ntprobnp Test Kits), Test Type (Laboratory Testing, Point-of-Care Testing), Component, Technology, Sales Channel, Application, End-user - Global Forecast 2025-2030

Report
195 Pages
November 2024
Region: Global
360iResearch™
ID: 6021491

UP TO €684EUR$697USD£571GBP OFF until Dec 31^st 2024

The Bnp & Ntprobnp Market grew from USD 1.76 billion in 2023 to USD 1.96 billion in 2024. It is expected to continue growing at a CAGR of 11.25%, reaching USD 3.73 billion by 2030.

B-type Natriuretic Peptide (BNP) and N-terminal pro b-type Natriuretic Peptide (NT-proBNP) are crucial biomarkers used primarily for diagnosing and managing heart failure as well as assessing cardiovascular risks. These peptides serve as valuable indicators of cardiac stress, with their levels rising in response to changes in heart function, making them indispensable tools in both clinical diagnostics and research applications. Given the increasing prevalence of cardiovascular diseases, the BNP and NT-proBNP testing market is witnessing substantial demand, driven by the need for early and accurate detection methods.

Key growth factors include technological advancements in testing methods, the rising prevalence of heart diseases, and expanding awareness about the benefits of early diagnosis. There's also a growing inclination towards point-of-care testing systems, providing opportunities for innovation in ease of use and rapid results in diverse settings, including hospitals and home care.

The market, however, faces limitations such as the high cost of advanced diagnostic techniques and limited awareness in emerging economies, which hinder the widespread adoption of these tests. Additionally, variability in test results due to differences in testing kits poses a challenge, stressing the need for standardized testing protocols. Opportunities lie in expanding the application of BNP and NT-proBNP testing for risk stratification in other cardiovascular conditions, personalized medicine, and integration with digital health technologies for improved monitoring and management. Investment in research and development towards enhanced biomarker specificity and sensitivity will be crucial.

Competitive strategies might focus on expanding into untapped emerging markets and lowering costs through innovation and partnerships. Developing AI-driven diagnostic tools can also be a game-changer, enabling more comprehensive and real-time analysis to augment traditional testing methods. Ultimately, the nature of this market is highly dynamic, with innovation continually reshaping testing methodologies and applications, necessitating agility and strategic foresight for sustained growth.

Understanding Market Dynamics in the Bnp & Ntprobnp Market

The Bnp & Ntprobnp Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing awareness about the benefits of early diagnosis and monitoring for heart-related ailments
- Growing prevalence of cardiovascular diseases and heart failure worldwide
- Supporting government policies and initiatives focusing on heart disease prevention and management
Market Restraints
- Variability in assay results due to lack of standardization
Market Opportunities
- Innovations in point-of-care natriuretic peptide tests to improve accessibility and adoption rates
- Expanding the use of NTproBNP in personalized medicine and precision health strategies
Market Challenges
- Challenges in interpreting biomarker levels due to factors such as renal function or obesity

Exploring Porter’s Five Forces for the Bnp & Ntprobnp Market

Porter’s Five Forces framework further strengthens the insights of the Bnp & Ntprobnp Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Bnp & Ntprobnp Market

External macro-environmental factors deeply influence the performance of the Bnp & Ntprobnp Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Bnp & Ntprobnp Market

The Bnp & Ntprobnp Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Bnp & Ntprobnp Market

The Bnp & Ntprobnp Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Bnp & Ntprobnp Market

The Bnp & Ntprobnp Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bnp & Ntprobnp Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Autobio Diagnostics Co., Ltd., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc, bioMérieux PLC, Chengdu Illumaxbio Technology Co., Ltd., F. Hoffmann-La Roche Ltd, Fujirebio China Co., Ltd., Gentian Diagnostics ASA, Getein Biotech, Inc., QuidelOrtho Corporation, Radiometer Medical ApS, Randox Laboratories Ltd., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., and Tosoh Europe N.V.

Market Segmentation & Coverage

This research report categorizes the Bnp & Ntprobnp Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Bnp Test Kits
- Ntprobnp Test Kits
Test Type
- Laboratory Testing
  - Chemiluminescent Immunoassay (CLIA)
  - Enzyme-linked Immunosorbent Assay (ELISA)
- Point-of-Care Testing
Component
- Analyzers & Devices
  - Benchtop Analyzers
  - Portable Analyzers
- Reagents & Kits
Technology
- Biosensors
- Immunoassays
- Microfluidics
Sales Channel
- Offline Sales
- Online Sales
Application
- Heart Failure Management
  - Acute Heart Failure
    - Cardiogenic Shock
    - Decompensated Heart Failure
  - Chronic Heart Failure
    - Biventricular Heart Failure
    - Left-Sided Heart Failure
    - Right-Sided Heart Failure
      - Cor Pulmonale
- Kidney Dysfunction
  - Acute Kidney Injury
  - Chronic Kidney Disease
- Risk Assessment
  - Prognostic Evaluation
    - Mortality Risk Assessment
    - Readmission Risk Assessment
  - Screening for Cardiovascular Diseases
End User
- Clinical Laboratories
  - Diagnostic Laboratories
    - Biochemistry Labs
    - Pathology Labs
  - Research Laboratories
- Hospitals & Clinics
- Research Institutes & Academia

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States (California, Florida, Illinois, New York, Ohio, Pennsylvania, Texas)
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing awareness about the benefits of early diagnosis and monitoring for heart-related ailments
5.1.1.2. Growing prevalence of cardiovascular diseases and heart failure worldwide
5.1.1.3. Supporting government policies and initiatives focusing on heart disease prevention and management
5.1.2. Restraints
5.1.2.1. Variability in assay results due to lack of standardization
5.1.3. Opportunities
5.1.3.1. Innovations in point-of-care natriuretic peptide tests to improve accessibility and adoption rates
5.1.3.2. Expanding the use of NTproBNP in personalized medicine and precision health strategies
5.1.4. Challenges
5.1.4.1. Challenges in interpreting biomarker levels due to factors such as renal function or obesity
5.2. Market Segmentation Analysis
5.2.1. Test Type: Rising preference for laboratory testing due to its high sensitivity and specificity
5.2.2. End User: Rising use of BNP and NT-proBNP in clinical laboratories due to their established protocols
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Bnp & Ntprobnp Market, by Type

6.1. Introduction
6.2. Bnp Test Kits
6.3. Ntprobnp Test Kits

7. Bnp & Ntprobnp Market, by Test Type

7.1. Introduction
7.2. Laboratory Testing
7.2.1. Chemiluminescent Immunoassay (CLIA)
7.2.2. Enzyme-linked Immunosorbent Assay (ELISA)
7.3. Point-of-Care Testing

8. Bnp & Ntprobnp Market, by Component

8.1. Introduction
8.2. Analyzers & Devices
8.2.1. Benchtop Analyzers
8.2.2. Portable Analyzers
8.3. Reagents & Kits

9. Bnp & Ntprobnp Market, by Technology

9.1. Introduction
9.2. Biosensors
9.3. Immunoassays
9.4. Microfluidics

10. Bnp & Ntprobnp Market, by Sales Channel

10.1. Introduction
10.2. Offline Sales
10.3. Online Sales

11. Bnp & Ntprobnp Market, by Application

11.1. Introduction
11.2. Heart Failure Management
11.2.1. Acute Heart Failure
11.2.1.1. Cardiogenic Shock
11.2.1.2. Decompensated Heart Failure
11.2.2. Chronic Heart Failure
11.2.2.1. Biventricular Heart Failure
11.2.2.2. Left-Sided Heart Failure
11.2.2.3. Right-Sided Heart Failure
11.2.2.3.1. Cor Pulmonale
11.3. Kidney Dysfunction
11.3.1. Acute Kidney Injury
11.3.2. Chronic Kidney Disease
11.4. Risk Assessment
11.4.1. Prognostic Evaluation
11.4.1.1. Mortality Risk Assessment
11.4.1.2. Readmission Risk Assessment
11.4.2. Screening for Cardiovascular Diseases

12. Bnp & Ntprobnp Market, by End User

12.1. Introduction
12.2. Clinical Laboratories
12.2.1. Diagnostic Laboratories
12.2.1.1. Biochemistry Labs
12.2.1.2. Pathology Labs
12.2.2. Research Laboratories
12.3. Hospitals & Clinics
12.4. Research Institutes & Academia

13. Americas Bnp & Ntprobnp Market

13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States

14. Asia-Pacific Bnp & Ntprobnp Market

14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam

15. Europe, Middle East & Africa Bnp & Ntprobnp Market

15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom

16. Competitive Landscape

16.1. Market Share Analysis, 2023
16.2. FPNV Positioning Matrix, 2023
16.3. Competitive Scenario Analysis
16.3.1. Siemens Healthineers transforms heart failure diagnosis with innovative NT-proBNPII assay integration
16.3.2. Roche Diagnostics pioneers NT-proBNP test for early CVD detection in diabetes patients via point-of-care systems
16.3.3. Innovative hs-cTnI and NT-proBNP assays by Mindray enhance cardiac diagnostics precision and patient care
16.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. BNP & NTPROBNP MARKET MULTI-CURRENCY
FIGURE 2. BNP & NTPROBNP MARKET MULTI-LANGUAGE
FIGURE 3. BNP & NTPROBNP MARKET RESEARCH PROCESS
FIGURE 4. BNP & NTPROBNP MARKET SIZE, 2023 VS 2030
FIGURE 5. GLOBAL BNP & NTPROBNP MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL BNP & NTPROBNP MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 13. GLOBAL BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 15. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
FIGURE 17. GLOBAL BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 19. GLOBAL BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. GLOBAL BNP & NTPROBNP MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 21. GLOBAL BNP & NTPROBNP MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. AMERICAS BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. AMERICAS BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 25. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 27. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 30. BNP & NTPROBNP MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 31. BNP & NTPROBNP MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. BNP & NTPROBNP MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BNP & NTPROBNP MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BNP & NTPROBNP MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BNP & NTPROBNP MARKET DYNAMICS
TABLE 7. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BNP & NTPROBNP MARKET SIZE, BY BNP TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BNP & NTPROBNP MARKET SIZE, BY NTPROBNP TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY (CLIA), BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BNP & NTPROBNP MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BNP & NTPROBNP MARKET SIZE, BY BENCHTOP ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BNP & NTPROBNP MARKET SIZE, BY PORTABLE ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BNP & NTPROBNP MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BNP & NTPROBNP MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BNP & NTPROBNP MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BNP & NTPROBNP MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BNP & NTPROBNP MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CARDIOGENIC SHOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BNP & NTPROBNP MARKET SIZE, BY DECOMPENSATED HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BNP & NTPROBNP MARKET SIZE, BY BIVENTRICULAR HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BNP & NTPROBNP MARKET SIZE, BY LEFT-SIDED HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BNP & NTPROBNP MARKET SIZE, BY COR PULMONALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ACUTE KIDNEY INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BNP & NTPROBNP MARKET SIZE, BY MORTALITY RISK ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BNP & NTPROBNP MARKET SIZE, BY READMISSION RISK ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BNP & NTPROBNP MARKET SIZE, BY SCREENING FOR CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BNP & NTPROBNP MARKET SIZE, BY BIOCHEMISTRY LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BNP & NTPROBNP MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BNP & NTPROBNP MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RESEARCH INSTITUTES & ACADEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 119. CANADA BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. CANADA BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 121. CANADA BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 122. CANADA BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 123. CANADA BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 124. CANADA BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. CANADA BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. CANADA BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. CANADA BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 128. CANADA BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 129. CANADA BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 130. CANADA BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 131. CANADA BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 132. CANADA BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 133. CANADA BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 134. CANADA BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. CANADA BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 136. CANADA BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 137. MEXICO BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. MEXICO BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 139. MEXICO BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 140. MEXICO BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 141. MEXICO BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 142. MEXICO BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. MEXICO BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. MEXICO BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. MEXICO BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 146. MEXICO BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 147. MEXICO BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 148. MEXICO BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 149. MEXICO BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 150. MEXICO BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 151. MEXICO BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 152. MEXICO BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. MEXICO BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 154. MEXICO BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 188. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 196. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 197. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 198. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 202. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 203. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 204. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 205. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 206. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 207. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 208. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 210. AUSTRALIA BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 211. CHINA BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. CHINA BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 213. CHINA BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 214. CHINA BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 215. CHINA BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 216. CHINA BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. CHINA BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. CHINA BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. CHINA BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 220. CHINA BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 221. CHINA BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 222. CHINA BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 223. CHINA BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 224. CHINA BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 225. CHINA BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 226. CHINA BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. CHINA BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 228. CHINA BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 229. INDIA BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. INDIA BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 231. INDIA BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 232. INDIA BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 233. INDIA BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 234. INDIA BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. INDIA BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. INDIA BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. INDIA BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 238. INDIA BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 239. INDIA BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 240. INDIA BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 241. INDIA BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 242. INDIA BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 243. INDIA BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 244. INDIA BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. INDIA BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 246. INDIA BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 247. INDONESIA BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. INDONESIA BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 249. INDONESIA BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 250. INDONESIA BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 251. INDONESIA BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 252. INDONESIA BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. INDONESIA BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. INDONESIA BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. INDONESIA BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 256. INDONESIA BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 257. INDONESIA BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 258. INDONESIA BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 259. INDONESIA BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 260. INDONESIA BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 261. INDONESIA BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 262. INDONESIA BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. INDONESIA BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 265. JAPAN BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. JAPAN BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 267. JAPAN BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 268. JAPAN BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 269. JAPAN BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 270. JAPAN BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 271. JAPAN BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. JAPAN BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. JAPAN BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 274. JAPAN BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 275. JAPAN BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 276. JAPAN BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 277. JAPAN BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 278. JAPAN BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 279. JAPAN BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 280. JAPAN BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. JAPAN BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 282. JAPAN BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 283. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 284. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 285. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 286. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 287. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 288. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 289. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 292. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 293. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 294. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 301. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 302. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 303. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 304. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 305. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 306. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 307. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 310. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 311. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 312. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 313. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 314. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 315. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 316. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 318. PHILIPPINES BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 319. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 320. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 321. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 322. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 323. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 324. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 325. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 326. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 328. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 329. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 330. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 331. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 332. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 333. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2030 (USD MILLION)
TABLE 334. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 336. SINGAPORE BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 337. SOUTH KOREA BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 338. SOUTH KOREA BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 339. SOUTH KOREA BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 340. SOUTH KOREA BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 341. SOUTH KOREA BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2030 (USD MILLION)
TABLE 342. SOUTH KOREA BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 343. SOUTH KOREA BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 344. SOUTH KOREA BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 345. SOUTH KOREA BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 346. SOUTH KOREA BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 347. SOUTH KOREA BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 348. SOUTH KOREA BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2030 (USD MILLION)
TABLE 349. SOUTH KOREA BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2030 (USD MILLION)
TABLE 350. SOUTH KOREA BNP & NTPROBNP MARKET SIZE, BY RISK ASSE

Companies Mentioned

Abbott Laboratories
Autobio Diagnostics Co., Ltd.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc
bioMérieux PLC
Chengdu Illumaxbio Technology Co., Ltd.
F. Hoffmann-La Roche Ltd
Fujirebio China Co., Ltd.
Gentian Diagnostics ASA
Getein Biotech, Inc.
QuidelOrtho Corporation
Radiometer Medical ApS
Randox Laboratories Ltd.
Siemens AG
Sysmex Corporation
Thermo Fisher Scientific Inc.
Tosoh Europe N.V.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	195
Published	November 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.96 billion
Forecasted Market Value ( USD ) by 2030	$ 3.73 billion
Compound Annual Growth Rate	11.2%
Regions Covered	Global
No. of Companies Mentioned	17

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3481EUR$3,545USD£2,904GBP €3868EUR$3,939USD£3,227GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6158EUR$6,272USD£5,138GBP €6843EUR$6,969USD£5,709GBP

Understanding Market Dynamics in the Bnp & Ntprobnp Market

Exploring Porter’s Five Forces for the Bnp & Ntprobnp Market

Applying PESTLE Analysis to the Bnp & Ntprobnp Market

Analyzing Market Share in the Bnp & Ntprobnp Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Bnp & Ntprobnp Market

Strategic Recommendations for Success in the Bnp & Ntprobnp Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

BNP and NTproBNP Global Market Report 2024

BNP And NTproBNP Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

Cardiac Biomarkers Market Size, Share & Trends Analysis Report By Type (Troponin, CK-MB, Myoglobin, BNP And NT-proBNP), By Application (Acute Coronary Syndrome, Myocardial Infarction), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Cardiac Biomarkers: Technologies and Global Markets

Cardiac Marker Market by Product, Biomarker Type, End-User, Indication - Global Forecast 2025-2030